Jul 29, 2024

Mankind Pharma Limited, a listed company, on the proposed acquisition of 100% stake in Bharat Serum from Advent.

AZB & Partners represented Mankind Pharma Limited, a listed company, on the proposed acquisition of 100% stake in Bharat Serum from Advent for approx 13,630 crores.

Our deal team comprised our Senior Partner Vaidhyanadhan Iyer, Partner Sneha Nagvekar, Senior Associate Sana Nagar, Senior Associate Karun Jhangiani, Associates Shivam Gupta and Akanksha Khandelwal. They were supported by Partner Nikunj Maheshwari, Counsel Nitika Jain, Associates Piyush Tiwari and Nikita Bhosle on financing aspects; our Partner Bharat V Budholia, Senior Associate Vayshnavi Ganesh, Associates Shaurya Kumar and Ileina Srivastav on competition law aspects; our Partners Nandan Pendsey, Esq., Ajay Singh Solanki, Senior Associates Veeral Vakharia, Rashmee Kumar, Rhea Ghanshani, Sayantani Saha, and Associates Rohan Puskur, Jay Singhee, Thangam Chandy, Tarini Mehtani and Rishav Sen on the due diligence aspects.

AUTHORS & CONTRIBUTORS

TAGS

SHARE

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.